by The global subcutaneous drug delivery devices market size is forecasted to hit from US$ 25.53 billion in 2021 to US$ 56.9 billion by 2030, growing at a CAGR of 9.3% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research. The rising adoption of the various subcutaneous drug delivery devices by consumers to control and manage their chronic health conditions is fueling market growth.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1490
This growth, according to the report, is due to the increased number of chronic disease prevalence around the globe, the significant number of vaccination and immunization programs that incorporate the use of subcutaneous drug delivery devices for therapeutic administration, and a rise in the R&D of new products leading to the subsequent introduction of novel solutions and devices in the market.
However, the risk of infections and other diseases associated with the use of injections and syringes is likely to hamper the market growth.
The study further states that the increased investment that companies are making into R&D is also aiding in the increase of the global subcutaneous drug delivery devices market.
COVID-19 has led to increasing in-home care treatments
COVID-19 cases have been increasing day by day almost all over the globe. The fatality of this virus especially for people already suffering from high blood pressure, diabetes, or other chronic diseases is tremendously high. People with these kinds of health issues prefer to stay at home and avoid going to any public places. Visiting hospitals, care centers or solo clinics for regular medication can be fatal or harmful for these patients. This pandemic situation thus has surged the demand for home medication drug delivery devices. Drug delivery devices providing self-medication abilities will help people to medicate themselves without stepping out of the house, thus saving them from dangerous impacts that the COVID-19 virus could cause.
Market Trends
The escalating awareness about the benefits of subcutaneous drug delivery devices is bringing tremendous growth opportunities. With a large number of individuals preferring eCommerce platforms for ordering these devices, the players are making efforts to increase their online presence. Novel devices are also creating a substantial buzz in the subcutaneous drug delivery devices market. Researchers at MIT recently developed a double-barreled syringe for subcutaneous biologics injections.
Wearable injectors may also bring a good growth share for the subcutaneous drug delivery devices market during the forecast period of 2021-2030.
Competitive Intelligence
The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.
Some of the prominent players in the global subcutaneous drug delivery devices market are listed as below:
- Insulet Corporation
- Enable Injections
- Amgen
- BD
- Consort Medical Plc
- Ypsomed AG
- Eli Lilly
- Novo Nordisk
- Sanofi
- Merck
- AstraZeneca
Segments Covered in the Report
By Product Type
- Auto-Injectors
- Pen Injectors
- Prefilled Syringes
- Wearable Injectors
- Needle-Free Injectors
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Subcutaneous Drug Delivery Devices Market
5.1. COVID-19 Landscape: Subcutaneous Drug Delivery Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Subcutaneous Drug Delivery Devices Market, By Product
8.1. Subcutaneous Drug Delivery Devices Market, by Product Type, 2021-2030
8.1.1. Auto-Injectors
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Pen Injectors
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Prefilled Syringes
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Wearable Injectors
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Needle-Free Injectors
8.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Subcutaneous Drug Delivery Devices Market, By Distribution Channel
9.1. Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2021-2030
9.1.1. Retail Pharmacies
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Hospital Pharmacies
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Online Pharmacies
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Subcutaneous Drug Delivery Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)
Chapter 11. Company Profiles
11.1. Insulet Corporation
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Enable Injections
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Amgen
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. BD
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Consort Medical Plc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Ypsomed AG
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Eli Lilly
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Novo Nordisk
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Sanofi
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Merck
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. AstraZeneca
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global subcutaneous drug delivery devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for subcutaneous drug delivery devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1490
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
